Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

BACKGROUND AND PURPOSE: Intravenous thrombolysis with tissue plasminogen activator is standard treatment in acute stroke today. The benefit of endovascular treatment has been questioned. Recently, studies evaluating endovascular treatment and intravenous thrombolysis compared with intravenous thromb...

Descripción completa

Detalles Bibliográficos
Autores principales: Falk-Delgado, Anna, Kuntze Söderqvist, Åsa, Fransén, Jian, Falk-Delgado, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Ischemic Stroke
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941179/
https://www.ncbi.nlm.nih.gov/pubmed/26138731
http://dx.doi.org/10.1136/neurintsurg-2015-011835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941179/
https://www.ncbi.nlm.nih.gov/pubmed/26138731
http://dx.doi.org/10.1136/neurintsurg-2015-011835

Ejemplares similares